Clinical Trial Update: Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-01 Study [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial (TPOP-01) evaluated prevention of posttraumatic stress disorder using a polyunsaturated fatty acid supplement in phase 1/2. The study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder
• Trauma

Drugs mentioned

• Polyunsaturated fatty acid supplement (polyunsaturated fatty acids)

Snippet

Sponsor: Japan Science and Technology Agency | Conditions: Trauma, Posttraumatic Stress Disorder | Phase 1, Phase 2 | Status: COMPLETED